EP1904490
Etanólamín salt af N-(3-metoxý-5-metýlpýrasín-2-ýl)-2-(4-[1,3,4-oxadíasól-2-ýl]fenýl)prýridín-3-súlfónamíði.
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
17.7.2006EP published:
29.9.2010EP application number:
06755779.3
EP translation filed:
11.11.2010Grant published:
15.12.2010EPO information:
European Patent Register
Max expiry date:
16.7.2026Expiry date:
16.7.2013
Title:
ETHANOLAMINE SALT OF N- (3-METHOXY-5-METHYLPYRAZIN-2YL) -2- (4- [1 , 3 , 4-0XADIAZ0LE-2-YL]PHENYL) PYRIDINE-3- SULPHONAMIDE
Timeline
Today
17.7.2006EP application
29.9.2010EP Publication
11.11.2010Translation submitted
15.12.2010Registration published
16.7.2013Expires
Owner
Name:
AstraZeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
GOOD, CatherineAddress:
Macclesfield Cheshire SK10 4TG, GB
Name:
HOGAN, Phillip JohnAddress:
Macclesfield Cheshire SK10 2NA, GB
Name:
MONTGOMERY, FrankAddress:
Macclesfield Cheshire SK10 4TG, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
0514743Date:
19.7.2005Country:
GB
Classification
Categories:
C07D 413/14, A61K 31/497, A61P 35/04
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 5.7.2011
Expires: 16.7.2012
Payer: Örn Þór, slf.
Number: 7
Paid: 8.6.2012
Expires: 16.7.2013
Payer: Sigurjónsson & Thor ehf.